Capstan Therapeutics

Biotechnology company focused on developing targeted in vivo RNA technologies. Capstan Therapeutics aims to expand therapeutic possibilities for patients through advanced RNA-based treatments, differentiating itself by its innovative approach to RNA delivery and targeting. The primary beneficiaries of Capstan Therapeutics' innovations are patients with conditions that can be treated or managed through RNA-based therapies.